The Grey Healthcare Group Award for Excellence in Health Improvement and Education

Finalist

Think Test for HIV

Bristol-Myers Squibb in association with Mash Health

Summary of work

Late diagnosis of HIV remains an issue in the UK, affecting morbidity and mortality. While guidelines set out criteria for testing outside the genitourinary medicine (GUM) setting, testing in other specialties remains low.

We worked with Bristol-Myers Squibb to develop a programme designed to increase HIV testing in non-GUM Secondary Care settings. In the 10 months since launch, the ‘Think Test for HIV’ initiative has been adopted in more than 38 hospitals. In one hospital, this has already resulted in a 60 per cent increase in HIV testing and a 13 per cent increase in early diagnosis – directly impacting on patients’ lives.

Executive summary as submitted

COVID-19 Updates and Daily News

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?: The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer: To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID-19 – a catalyst for technology adoption in clinical trials: As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...